Note: Ingredients listed on restricted chemical lists
EC/CAS
204-886-1/128-44-9
Name of the chemical
1,2-benzisothiazol-3(2H)-one 1,1-dioxide, sodium salt
Concentration
N/A
EC/CAS
201-069-1/77-92-9
Name of the chemical
Citric acid
Concentration
<1
EC/CAS
231-791-2/7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
limit (SCL
EC/CAS
200-334-9/57-50-1
Name of the chemical
Sucrose, pure C12H22O11
Concentration
N/A
EC/CAS
208-534-8/532-32-1
Name of the chemical
Benzoic acid and its sodium salt
Concentration
N/A
General Information
Version
5
Revision date
2025-06-14
Product name
Ethosuximide Syrup
Product name
Ethosuximide Syrup
Identification on the label/Trade name
Zarontin; Suxinutin
Chemical name
Mixture
1.2.1 Relevant identified uses
Pharmaceutical product used as anticonvulsant anti-epileptic
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H341, H360D
Hazard statements
Code
Statements
H341
Suspected of causing genetic defects
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Danger
Hazard statements
H341 - Suspected of causing genetic defects H360D - May damage the unborn child
Precautionary statements
P201 - Obtain special instructions before use P202 - Do not handle until all safety precautions have been read and understood P280 - Wear protective gloves/protective clothing/eye protection/face protection P308 + P313 - IF exposed or concerned: Get medical advice/attention P405 - Store locked up P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable 0.022 % of the mixture consists of ingredient(s) of unknown acute oral toxicity. 36.272 % of the mixture consists of ingredient(s) of unknown acute dermal toxicity. 36.272 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (dust/mist). 43.242 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (gas). 43.242 % of the mixture consists of ingredient(s) of unknown acute inhalation toxicity (vapor). Unknown aquatic toxicity Contains 0.022 % of components with unknown hazards to the aquatic environment. Contains Glycerin, USP, Ethosuximide
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Germ cell mutagenicity Category 2 - (H341) Reproductive toxicity Category 1B - (H360D) OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
